Current Context of Designing Phototheranostic Cyclometalated Iridium (III) Complexes to Open a New Avenue in Cancer Therapy
ChemMedChem · 2025
DOI: 10.1002/cmdc.202400649 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ChemMedChem, 2025. Verfasst von Sreelekha U und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, School of Advanced Sciences, Vellore Institute of Technology, Vellore, 632014, Tamil Nadu, India. Hauptthemen laut MEDLINE: Iridium, Coordination Complexes, Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 152 Literaturangaben.
Abstract (Originalsprache)
Photo‐induced chemotherapy offers the best option for the selective treatment of cancer among all the prevailing modalities. Iridium (III) complexes, flourished with excellent photophysical and photochemical properties, have been considered to be superior for undergoing photo‐responsive cancer therapy. Large Stokes shift, long‐lived triplet excited state, photostability, and tuneable emission have rendered its excellence as a phototheranostic agent. In particular, the cyclometalated Ir (III) complexes and their respective nanoparticles have made a strong niche in the arena of cancer therapy. In recent years, Ir (III) based complexes have shown promising utilities as both imaging and therapeutic agents as well. Therefore, this review summarises the recent advances in the strategic designing of cyclometalated Ir(III) complexes to augment their phototheranostic applications in precision medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, School of Advanced Sciences, Vellore Institute of Technology, Vellore, 632014, Tamil Nadu, India.
- Department of Chemistry, Birla Institute of Technology & Science, Pilani K K Birla Goa Campus, NH 17 B, Zuarinagar, Goa, India.
ORCID-Profile: Uttara Basu, Priyankar Paira
Zitieren
APA
U, S., Basu, U., & Paira, P. (2025). Current Context of Designing Phototheranostic Cyclometalated Iridium (III) Complexes to Open a New Avenue in Cancer Therapy. ChemMedChem. https://doi.org/10.1002/cmdc.202400649
Vancouver
U S, Basu U, Paira P. Current Context of Designing Phototheranostic Cyclometalated Iridium (III) Complexes to Open a New Avenue in Cancer Therapy. ChemMedChem. 2025. doi:10.1002/cmdc.202400649
BibTeX
@article{U2025,
author = {U, Sreelekha and Basu, Uttara and Paira, Priyankar},
title = {Current Context of Designing Phototheranostic Cyclometalated Iridium (III) Complexes to Open a New Avenue in Cancer Therapy},
journal = {ChemMedChem},
year = {2025},
doi = {10.1002/cmdc.202400649}
}
EUVIMED